Mail & Guardian
Mail & Guardian

Cab La

latest news & developments
A programme meant to allow pharmacists and nurses working at private pharmacies to prescribe HIV treatment or anti-HIV pills and jabs is on hold because of a drawn-out court case
ARVS

Popping into your local pharmacy for anti-HIV pills and jabs could help slow new infections. So why is it not allowed in SA?

A programme meant to allow pharmacists and nurses working at private pharmacies to prescribe HIV treatment or anti-HIV pills and jabs is on hold because of a drawn-out court case

  • Angela Tembo
  • Tsitsi Nyamuzihwa
7 min read
CAB-LA, a long-acting HIV prevention shot is currently being trailed in 3 200 women across Sub-Saharan Africa. (Yolanda Mdzeke, Bhekisisa)
ANTI HIV INJECTION

Anti-HIV injection to be made in SA

CAB-LA will be made at Indian drug company Cipla’s Benoni and Durban plants, but a starting date for production has not yet been announced

  • Zano Kunene
10 min read
From paper to provinces: Find out how far South African provinces have come in implementing the country’s national HIV and TB plan. (Vladimir Konstantinov)
CAB LA

South Africa’s medicine regulator has approved an anti-HIV jab, CAB-LA

But for how much will drugmaker ViiV Healthcare sell it to the government? We asked them in our TV programme, Health Beat

  • Mia Malan
  • Mohale Moloi
8 min read
Of the 30 countries the World Health Organisation has identified as having a high burden of TB and HIV co-infections, 22 are in sub-Saharan Africa. Photo: MUJAHID SAFODIEN/AFP/Getty Images)
CAB LA

What’s the use of anti-HIV injections when those who need it most can’t use it?

A new HIV prevention medicine could work even better than daily pills but if nothing changes it costs more than R300 000 to treat one person for a year

  • Yogan Pillay, Francois Venter & Fatima Hassan
12 min read
The Botswana Network on Ethics, Law and HIV/Aids says the crisis is not an isolated supply-chain issue but a ‘systemic failure’ that demands urgent government intervention
CAB LA

FDA approval of injectable HIV prevention drug an important milestone for sub-Saharan Africa

The CAB-LA injection is the first of its kind in HIV prevention interventions and only needs to be taken every eight weeks

  • Marcia Zali
2 min read